New leprosy case detection rate per 1 000 000 population in Andorra
Andorra: New leprosy case detection rate per 1 000 000 population was 0 in 2024. ◆ Volatile
Latest (2024)
0
World rank
124th
of 171 countries
All-time high
12.53
in 2022
All-time low
0
in 2015
Years of data
9
2015–2024
New leprosy case detection rate per 1 000 000 population in Andorra, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, new leprosy case detection rate per 1 000 000 population in Andorra stood at 0. That is the lowest value across all 9 years on record.
Over the whole period, new leprosy case detection rate per 1 000 000 population in Andorra peaked at 12.53 in 2022 and was at its lowest, 0, in 2015.
Andorra ranks 124th of 171 countries on this measure, in the middle of the range.
New leprosy case detection rate per 1 000 000 population in Andorra, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 12.53 | — |
| 2023 | 0 | -100.0% |
| 2024 | 0 | — |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0 | 0 | 0 | 4 |
| 2020s | 2.51 | 0 | 12.53 | 5 |
Countries ranked near Andorra
- 121 Canada 0.075 compare
- 122 Iraq 0.065 compare
- 123 Germany 0.012 compare
- 124 Norway 0 compare
- 124 San Marino 0
- 124 Antigua and Barbuda 0
- 124 Lithuania 0
- 124 Bahamas 0 compare
- 124 Belize 0 compare
- 124 Saint Vincent and the Grenadines 0 compare
- 124 Sao Tome and Principe 0 compare
- 124 Guatemala 0 compare
- 124 Grenada 0 compare
- 124 Honduras 0 compare
- 124 Niue 0
- 124 Georgia 0
- 124 Lebanon 0 compare
- 124 Iceland 0
- 124 Latvia 0
- 124 Kazakhstan 0 compare
- 124 Austria 0
- 124 Tonga 0 compare
- 124 Dominica 0
- 124 Syrian Arab Republic 0 compare
- 124 Belarus 0
- 124 Monaco 0
- 124 Luxembourg 0
- 124 Slovenia 0
- 124 Finland 0
- 124 Jordan 0
- 124 Slovakia 0
- 124 Korea, Democratic People's Republic of 0
- 124 Brunei Darussalam 0 compare
- 124 Mongolia 0
- 124 Seychelles 0 compare
- 124 Armenia 0
- 124 Cook Islands 0
- 124 Saint Kitts and Nevis 0
- 124 Estonia 0
- 124 Barbados 0 compare
- 124 Algeria 0 compare
- 124 Malta 0 compare
- 124 Bosnia and Herzegovina 0
- 124 Bulgaria 0
- 124 Djibouti 0 compare
- 124 Croatia 0
- 124 Cyprus 0
- 124 Romania 0
- 124 Belgium 0 compare
- 124 Naoero 0 compare
More health data for Andorra
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2077)
- Heat deaths vs projected death rates 1,824 (2090)
- Heat deaths vs projected death rates, annual growth rate 0.0878 % change on previous year (2090)
- Un projection of annual infant deaths 0 (2100)
- Age population, age 07, female, interpolated 296 (2025)
- Age population, age 09, male, interpolated 371 (2025)
- Age population, age 09, female, interpolated 345 (2025)
- Age population, age 08, male, interpolated 358 (2025)
- Age population, age 08, female, interpolated 329 (2025)
- Age population, age 07, male, interpolated 329 (2025)
Frequently asked questions
- What is new leprosy case detection rate per 1 000 000 population in Andorra?
- New leprosy case detection rate per 1 000 000 population in Andorra was 0 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest new leprosy case detection rate per 1 000 000 population recorded in Andorra?
- The highest recorded value was 12.53 in 2022.
- What is the lowest new leprosy case detection rate per 1 000 000 population recorded in Andorra?
- The lowest recorded value was 0 in 2015.
- How does Andorra rank for new leprosy case detection rate per 1 000 000 population?
- Andorra ranks 124th out of 171 countries with data for 2024.
- Where does this Andorra data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of New leprosy case detection rate per 1 000 000 population. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).